Nordicus Partners Corp (NORD)

[e-ore]

Another study which chose an ASNB product. Too bad it hasn't meant any increase in product sales.

The aromatic PCU ChronoFlex AR (CF, AdvanSource Biomaterials, Wilmington, MA, USA) was processed according to the manufacturer's instructions

"Polycarbonate urethanes (PCUs) have been used in implantable medical devices because of their superior biocompatibility, attractive mechanical properties, and improved oxidative biostability [1–5]. However, thrombus formation may still occur when artificial organs and biomedical devices made of PCU are in contact with blood for extended periods of time [6–8].
Currently this is managed by anti-platelet therapy, however, this presents a risk of bleeding[8]. Therefore, there remains a pressing need for non-thrombogenic surface coatings that can reduce this reliance on pharmacological intervention."

http://www.mdpi.com/search?q=CHRONOFLEX